Literature DB >> 10878393

Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.

T Namekawa1, M R Snyder, J H Yen, B E Goehring, P J Leibson, C M Weyand, J J Goronzy.   

Abstract

Expansion of CD4+CD28null T cells is a characteristic finding in patients with rheumatoid arthritis. Despite lacking CD28 molecules, these unusual CD4 T cells undergo clonal proliferation and form large and long-lived clonal populations. They produce high levels of IFN-gamma, exhibit autoreactivity, and have cytolytic function. The mechanisms facilitating the expansion and longevity of CD4+CD28null T cell clones in vivo are unknown. Here, we report that CD4+CD28null, but not CD4+CD28+, T cells express MHC class I-recognizing receptors normally found on NK cells. CD4+CD28null T cells preferentially expressed killer cell activating receptors (KAR), often in the absence of killer cell inhibitory receptors. Cross-linking of KAR molecules enhanced the proliferative response to TCR-mediated stimulation, but not the cytolytic function of CD4+CD28null T cells, suggesting different signaling pathways in CD4 T cells and NK cells. Triggering of KAR signaling led to the phosphorylation of several cellular targets, although the pattern of phosphorylation differed from that induced by the TCR. Aberrant expression of KAR molecules in the absence of inhibitory receptors and in the appropriate HLA setting may lead to the clonal outgrowth of autoreactive CD4+CD28null T cells commonly seen in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878393     DOI: 10.4049/jimmunol.165.2.1138

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Authors:  Andras Komocsi; Peter Lamprecht; Elena Csernok; Antje Mueller; Konstanze Holl-Ulrich; Ulrike Seitzer; Frank Moosig; Armin Schnabel; Wolfgang Ludwig Gross
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 2.  Adaptive immune responses mediated by natural killer cells.

Authors:  Silke Paust; Balimkiz Senman; Ulrich H von Andrian
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages.

Authors:  Stefan O Schönland; Consuelo Lopez; Thomas Widmann; Julia Zimmer; Ewa Bryl; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

4.  Finding Balance: T cell Regulatory Receptor Expression during Aging.

Authors:  Mary M Cavanagh; Qian Qi; Cornelia M Weyand; Jörg J Goronzy
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

5.  [How do T-cells become activated in joints?].

Authors:  M Pierer; U Wagner
Journal:  Z Rheumatol       Date:  2010-10       Impact factor: 1.372

Review 6.  The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

Authors:  Jeroen van Bergen; Frits Koning
Journal:  Immunology       Date:  2010-08-17       Impact factor: 7.397

7.  Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration.

Authors:  Sophia E Steer; Frances M K Williams; Bernet Kato; Jeffry P Gardner; Paul J Norman; Margaret A Hall; Masayuki Kimura; Robert Vaughan; Abraham Aviv; Tim D Spector
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

8.  Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.

Authors:  C Duftner; C Dejaco; W Kullich; A Klauser; C Goldberger; A Falkenbach; M Schirmer
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

9.  A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Authors:  Xianghong Chen; Fanqi Bai; Lubomir Sokol; Junmin Zhou; Amy Ren; Jeffrey S Painter; Jinhong Liu; David A Sallman; Y Ann Chen; Jeffrey A Yoder; Julie Y Djeu; Thomas P Loughran; Pearlie K Epling-Burnette; Sheng Wei
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

10.  ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis.

Authors:  Karnail Singh; Pratima Deshpande; Sergey Pryshchep; Inés Colmegna; Vladimir Liarski; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.